9.3.1 ABSTRACT: CYTOGENETICS Director: Betsy Hirsch, Ph.D. The Cytogenetics shared resource provides cell culture, karyotype analysis, and molecular cytogenetic services (including fluorescence-in-situ-hybridization and oligonudeotide array based comparative gendmic hybridization) for evaluation of human and animal cells. The Cytogenetics Core has worked with 20 different investigators representing five different programs within the Cancer Center. Over the past five years, the Core has expanded its services to meet the needs of these investigators. Examples include detailed chromosome breakage studies of mouse and human cells for evaluation of genes involved in DMA repair and maintenance of chromosome stability, sequential G-banding to SKY and FISH for mapping of transposon insertion sites, and array-CGH for the evaluation of subtle genomic copy number changes. These analyses have provided novel information to investigators that is pivotal to their future research programs. In addition, the Core has provided hundreds of conventional karyotype analyses as critical quality control measures for experiments involving genetically manipulated cells or populations of cells that have been expanded in-vitro. Karyotype verification is often a prerequisite for publication of such work: With an expanding repertoire of techniques, the Core has also focused on consultative assistance in experimental design and selection of cytogenetic and/or molecular cytogenetic techniques. Significant time is devoted to personal meetings with researchers to discuss the results and interpretation of analyses, and provide direction for future research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA077598-12
Application #
8044097
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-02-01
Budget End
2011-01-31
Support Year
12
Fiscal Year
2010
Total Cost
$63,061
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Owen, David L; Mahmud, Shawn A; Vang, Kieng B et al. (2018) Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis. J Immunol 200:3926-3933
Rashidi, Armin; Shanley, Ryan; Yohe, Sophia L et al. (2018) Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples. Bone Marrow Transplant 53:1069-1071
Widen, John C; Kempema, Aaron M; Baur, Jordan W et al. (2018) Helenalin Analogues Targeting NF-?B p65: Thiol Reactivity and Cellular Potency Studies of Varied Electrophiles. ChemMedChem 13:303-311
Springer, Simeon U; Chen, Chung-Hsin; Rodriguez Pena, Maria Del Carmen et al. (2018) Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. Elife 7:
Xu, Bin; Magli, Alessandro; Anugrah, Yoska et al. (2018) Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy. Biomaterials 183:54-66
Nikodemova, Maria; Yee, Jeremiah; Carney, Patrick R et al. (2018) Transcriptional differences between smokers and non-smokers and variance by obesity as a risk factor for human sensitivity to environmental exposures. Environ Int 113:249-258
Rashidi, Armin; Shanley, Ryan; Anasetti, Claudio et al. (2018) Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD. Bone Marrow Transplant :
Lin, Lifeng; Chu, Haitao (2018) Bayesian multivariate meta-analysis of multiple factors. Res Synth Methods 9:261-272
Mondragon-Gonzalez, Ricardo; Perlingeiro, Rita C R (2018) Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery. Dis Model Mech 11:
Kim, J-H; Frantz, A M; Sarver, A L et al. (2018) Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers. Vet Comp Oncol 16:E176-E184

Showing the most recent 10 out of 1013 publications